Advanced Cancer Clinical Trial
Official title:
Efficacy of Self-education Program for Advanced Care Planning: A Randomized Controlled Trial
This study verifies efficacy of Self-education program for advanced care planning. Half of participants will receive a book and videos about advanced care planning while the other half will receive a book and videos about pain control for cancer patients.
This study validates effectiveness of educational materials that the investigators developed
due to the rates of completing advanced care planning are considerably low and patients
relatively less less preferred to receive palliative care and hospice at terminal status,
which is led by the lack of information available to patients; whether these decision aids
change end-of-life care preference, elevate the preference of patients toward advanced care
planning, reduce the burden of decision making compare to educational resources that are
currently available.
Previous studies inform that educational video about advanced care planning increases the
knowledge of care for life prolongation, and affects the preference towards care for life
prolongation and palliative care. However, being no resources are provided and orally
explained, patients in the control group don't have enough time to fully aware of the
information, also, since those studies are done mostly in the western countries, 'discussing
with family members or guardians' part is missing, which is critical under contemporary
Korean medical society. This study provides educational resources to both the intervention
group and the control group and identifies if advanced care planning is discussed with family
members or guardians.
Primary outcome of this study is end-of-life care preference. Participants of this study will
fill out the baseline questionnaire about end-of-life care preference, end-of-life discussion
and documentation, knowledge of ACP, etc. After that, participants will be allocated equally
into the intervention group and the control group. The intervention group will receive a book
and videos about advanced care planning which are based on Smart Management Strategy for
Health(SMASH). The control group will receive a book and videos about pain control for cancer
patients that were provided by Korea National Cancer Center. After reading and watching the
educational materials, patients will get another questionnaire about knowledge of ACP,
satisfaction on the materials, end-of-life care preference, and decision role preference.
Participants will read and watch the materials for about 6-8 weeks and then they will be
asked to complete another questionnaire which includes every questions from the baseline and
post-intervention. The result from all three questionnaires (baseline, post-intervention,
7-week questionnaire) will be compiled and be compared with one another.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03181854 -
Randomized Controlled Trial of Integrated Early Palliative Care
|
N/A | |
Completed |
NCT01197170 -
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
|
Phase 1 | |
Recruiting |
NCT05045040 -
Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03994601 -
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Completed |
NCT01393990 -
A Study of LY2228820 in Participants With Advanced Cancer
|
Phase 1 | |
Completed |
NCT02857270 -
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT04121676 -
Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer
|
Phase 1 | |
Active, not recruiting |
NCT03177291 -
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC
|
Phase 1 | |
Completed |
NCT03980041 -
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
|
Phase 2 | |
Active, not recruiting |
NCT03674567 -
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
|
Phase 1/Phase 2 | |
Recruiting |
NCT04823377 -
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
|
N/A | |
Completed |
NCT02778126 -
A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer
|
Phase 1 | |
Completed |
NCT02507544 -
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
|
Phase 1 | |
Completed |
NCT02529553 -
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
|
Phase 1 | |
Completed |
NCT02245204 -
Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers
|
Phase 1 | |
Completed |
NCT01901237 -
Yoga for Adolescent and Young Adult Non-Curative Cancer Patients
|
N/A | |
Completed |
NCT01583777 -
Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer
|
Phase 1 |